CD8A and relapsing-remitting multiple sclerosis: Here, we studied the utility of combining MRI brain age with measures of CD8+CD57+(ILT2+PD-1+) T-cells in predicting disability in a predominantly relapsing-remitting MS (RRMS) patient cohort (n = 184, 19–65).